151 related articles for article (PubMed ID: 21764107)
1. The measurement of SUVmax of the primary tumor is predictive of prognosis for patients with endometrial cancer.
Nakamura K; Hongo A; Kodama J; Hiramatsu Y
Gynecol Oncol; 2011 Oct; 123(1):82-7. PubMed ID: 21764107
[TBL] [Abstract][Full Text] [Related]
2. Measurement of the minimum apparent diffusion coefficient (ADCmin) of the primary tumor and CA125 are predictive of disease recurrence for patients with endometrial cancer.
Nakamura K; Imafuku N; Nishida T; Niwa I; Joja I; Hongo A; Kodama J; Hiramatsu Y
Gynecol Oncol; 2012 Feb; 124(2):335-9. PubMed ID: 22008707
[TBL] [Abstract][Full Text] [Related]
3. Preoperative risk stratification using (18)F-FDG PET/CT in women with endometrial cancer.
Lee HJ; Ahn BC; Hong CM; Song BI; Kim HW; Kang S; Jeong SY; Lee SW; Lee J
Nuklearmedizin; 2011; 50(5):204-13. PubMed ID: 21727990
[TBL] [Abstract][Full Text] [Related]
4. The predictive value of measurement of SUVmax and SCC-antigen in patients with pretreatment of primary squamous cell carcinoma of cervix.
Nakamura K; Okumura Y; Kodama J; Hongo A; Kanazawa S; Hiramatsu Y
Gynecol Oncol; 2010 Oct; 119(1):81-6. PubMed ID: 20580064
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of preoperative metabolic tumor volume measured by ¹⁸F-FDG PET/CT and MRI in patients with endometrial cancer.
Chung HH; Lee I; Kim HS; Kim JW; Park NH; Song YS; Cheon GJ
Gynecol Oncol; 2013 Sep; 130(3):446-51. PubMed ID: 23791826
[TBL] [Abstract][Full Text] [Related]
6. The SUVmax of 18F-FDG PET correlates with histological grade in endometrial cancer.
Nakamura K; Kodama J; Okumura Y; Hongo A; Kanazawa S; Hiramatsu Y
Int J Gynecol Cancer; 2010 Jan; 20(1):110-5. PubMed ID: 20130510
[TBL] [Abstract][Full Text] [Related]
7. The pretreatment of maximum standardized uptake values (SUVmax) of the primary tumor is predictor for poor prognosis for patients with epithelial ovarian cancer.
Nakamura K; Hongo A; Kodama J; Hiramatsu Y
Acta Med Okayama; 2012; 66(1):53-60. PubMed ID: 22358139
[TBL] [Abstract][Full Text] [Related]
8. SUVmax of 18FDG PET/CT as a predictor of high-risk endometrial cancer patients.
Antonsen SL; Loft A; Fisker R; Nielsen AL; Andersen ES; Høgdall E; Tabor A; Jochumsen K; Fagö-Olsen CL; Asmussen J; Berthelsen AK; Christensen IJ; Høgdall C
Gynecol Oncol; 2013 May; 129(2):298-303. PubMed ID: 23376805
[TBL] [Abstract][Full Text] [Related]
9. The preoperative maximum standardized uptake value measured by 18F-FDG PET/CT as an independent prognostic factor of overall survival in endometrial cancer patients.
Walentowicz-Sadlecka M; Malkowski B; Walentowicz P; Sadlecki P; Marszalek A; Pietrzak T; Grabiec M
Biomed Res Int; 2014; 2014():234813. PubMed ID: 24719847
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of SUVmax and metabolic tumor volume on 18F-FDG PET/CT in early stage non-small cell lung cancer patients without LN metastasis.
Yoo IeR; Chung SK; Park HL; Choi WH; Kim YK; Lee KY; Wang YP
Biomed Mater Eng; 2014; 24(6):3091-103. PubMed ID: 25227018
[TBL] [Abstract][Full Text] [Related]
11. Tailoring systematic lymphadenectomy in high-risk clinical early stage endometrial cancer: the role of 18F-FDG PET/CT.
Crivellaro C; Signorelli M; Guerra L; De Ponti E; Pirovano C; Fruscio R; Elisei F; Montanelli L; Buda A; Messa C
Gynecol Oncol; 2013 Aug; 130(2):306-11. PubMed ID: 23707673
[TBL] [Abstract][Full Text] [Related]
12. Role of FDG-PET/CT in evaluating surgical outcomes of operable breast cancer--usefulness for malignant grade of triple-negative breast cancer.
Ohara M; Shigematsu H; Tsutani Y; Emi A; Masumoto N; Ozaki S; Kadoya T; Okada M
Breast; 2013 Oct; 22(5):958-63. PubMed ID: 23756383
[TBL] [Abstract][Full Text] [Related]
13. Volume-based parameters measured by using FDG PET/CT in patients with stage I NSCLC treated with stereotactic body radiation therapy: prognostic value.
Satoh Y; Onishi H; Nambu A; Araki T
Radiology; 2014 Jan; 270(1):275-81. PubMed ID: 24029640
[TBL] [Abstract][Full Text] [Related]
14. Preoperative serum CA125: a useful marker for surgical management of endometrial cancer.
Jiang T; Huang L; Zhang S
BMC Cancer; 2015 May; 15():396. PubMed ID: 25964114
[TBL] [Abstract][Full Text] [Related]
15. Preoperative serum levels of YKL 40 and CA125 as a prognostic indicators in patients with endometrial cancer.
Kotowicz B; Fuksiewicz M; Jonska-Gmyrek J; Wagrodzki M; Kowalska M
Eur J Obstet Gynecol Reprod Biol; 2017 Aug; 215():141-147. PubMed ID: 28624692
[TBL] [Abstract][Full Text] [Related]
16. Standardized uptake value and apparent diffusion coefficient of endometrial cancer evaluated with integrated whole-body PET/MR: Correlation with pathological prognostic factors.
Shih IL; Yen RF; Chen CA; Chen BB; Wei SY; Chang WC; Sheu BC; Cheng WF; Tseng YH; Chen XJ; Chen CH; Wei LH; Chiang YC; Torng PL; Yen ML; Shih TT
J Magn Reson Imaging; 2015 Dec; 42(6):1723-32. PubMed ID: 25919115
[TBL] [Abstract][Full Text] [Related]
17. Volume-based parameters of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography improve outcome prediction in early-stage non-small cell lung cancer after surgical resection.
Hyun SH; Choi JY; Kim K; Kim J; Shim YM; Um SW; Kim H; Lee KH; Kim BT
Ann Surg; 2013 Feb; 257(2):364-70. PubMed ID: 22968069
[TBL] [Abstract][Full Text] [Related]
18. [SUVmax measured by 18F FDG PET/CT in the primary tumor in relation to clinical and pathological features of endometrial cancer].
Walentowicz-Sadłecka M; Sadłecki P; Małecki B; Walentowicz P; Marszałek A; Domaracki P; Grabiec M
Ginekol Pol; 2013 Sep; 84(9):748-53. PubMed ID: 24191511
[TBL] [Abstract][Full Text] [Related]
19. Role of SUVmax and GLUT-1 Expression in Determining Tumor Aggressiveness in Patients With Clinical Stage I Endometrioid Endometrial Cancer.
Lee DW; Chong GO; Lee YH; Hong DG; Cho YL; Jeong SY; Park JY; Lee YS
Int J Gynecol Cancer; 2015 Jun; 25(5):843-9. PubMed ID: 25347093
[TBL] [Abstract][Full Text] [Related]
20. Metabolic tumour volume and total lesion glycolysis, measured using preoperative 18F-FDG PET/CT, predict the recurrence of endometrial cancer.
Shim SH; Kim DY; Lee DY; Lee SW; Park JY; Lee JJ; Kim JH; Kim YM; Kim YT; Nam JH
BJOG; 2014 Aug; 121(9):1097-106; discussion 1106. PubMed ID: 24397772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
